Prestige Consumer Healthcare Inc. (PBH) Stock Price

PBHStock

$52.47−21.99%52W

Market Cap$2.49B

P/E12.71x

PEG Ratio1.57

Div yield—

Beta0.33

PBH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-35.65%

Price vs S&P 500 (4W)-0.48%

PEG Ratio1.57

VGM Score53.49

P/E Ratio (Annual)12.71x

P/CF (Annual)9.39x

Book Value / Share (Quarterly)$40.46

Revenue Growth (3Y)-1.17%

Cash Flow / Share (Quarterly)$4.97

Price vs S&P 500 (YTD)-27.77%

Gross Margin (TTM)53.53%

Net Profit Margin (TTM)15.57%

EPS (TTM)$3.57

10-Day Avg Trading Volume0.41M

EPS Excl Extra (TTM)$3.57

Revenue Growth (5Y)2.91%

EPS (Annual)$3.91

ROI (Annual)6.55%

Gross Margin (Annual)54.71%

Net Profit Margin (5Y Avg)13.31%

Cash / Share (Quarterly)$1.88

P/E Basic Excl Extra (TTM)14.06x

Revenue Growth QoQ (YoY)6.48%

EPS Growth (5Y)3.71%

P/E Normalized (Annual)12.71x

ROA (Last FY)5.45%

Revenue Growth TTM (YoY)-1.36%

EBITD / Share (TTM)$6.47

ROE (5Y Avg)8.35%

Operating Margin (TTM)26.26%

Cash Flow / Share (Annual)$5.21

P/B Ratio1.26x

P/B Ratio (Quarterly)1.17x

Net Income / Employee (Annual)$317,200

EV / Revenue (TTM)3.96x

Net Interest Coverage (TTM)7.08x

ROA (TTM)4.59%

EPS Growth QoQ (YoY)-35.65%

EV / EBITDA (TTM)14.03x

EPS Incl Extra (Annual)$3.91

Current Ratio (Annual)3.57x

Quick Ratio (Quarterly)1.80x

3-Month Avg Trading Volume0.65M

52-Week Price Return-21.99%

EV / Free Cash Flow (Annual)17.74x

P/E Incl Extra (TTM)14.06x

Revenue / Employee (TTM)$1,841,500

Tangible BV / Share (Quarterly)$-26.59

P/S Ratio (Annual)2.22x

Asset Turnover (Annual)0.31x

52-Week High$71.07

Operating Margin (5Y Avg)23.32%

EPS Excl Extra (Annual)$3.91

CapEx CAGR (5Y)-12.82%

26-Week Price Return-23.72%

Quick Ratio (Annual)2.12x

13-Week Price Return8.25%

Total Debt / Equity (Annual)0.54x

Current Ratio (Quarterly)3.23x

Enterprise Value$4.37B

Revenue / Share Growth (5Y)3.69%

Asset Turnover (TTM)0.29x

Book Value / Share Growth (5Y)7.94%

Revenue / Employee (Annual)$1,814,500

Inventory Turnover (Annual)3.21x

Pretax Margin (Annual)23.65%

Cash / Share (Annual)$1.35

3-Month Return Std Dev35.41%

Gross Margin (5Y Avg)55.70%

Net Income / Employee (TTM)$286,700

EBITDA CAGR (5Y)1.35%

EBITDA Interim CAGR (5Y)-9.73%

ROE (Last FY)10.08%

Net Interest Coverage (Annual)6.08x

EPS Basic Excl Extra (Annual)$3.91

P/FCF (TTM)10.28x

Receivables Turnover (TTM)6.21x

EV / Free Cash Flow (TTM)18.57x

Total Debt / Equity (Quarterly)1.06x

EPS Incl Extra (TTM)$3.57

Receivables Turnover (Annual)5.64x

ROI (TTM)5.47%

P/S Ratio (TTM)2.19x

Pretax Margin (5Y Avg)17.80%

Revenue / Share (Annual)$22.35

Tangible BV / Share (Annual)$-28.62

Forward P/E11.39x

Free OCF CAGR (5Y)2.92%

Price vs S&P 500 (52W)-40.55%

P/E Ratio (TTM)14.06x

EPS Growth TTM (YoY)-16.21%

Year-to-Date Return-14.95%

5-Day Price Return0.87%

EPS Normalized (Annual)$3.91

ROA (5Y Avg)4.24%

Net Profit Margin (Annual)17.48%

Month-to-Date Return4.48%

Cash Flow / Share (TTM)$-1.01

EBITD / Share (Annual)$6.78

EPS Growth (3Y)1.99%

Operating Margin (Annual)28.42%

LT Debt / Equity (Annual)0.53x

P/CF (TTM)9.70x

ROI (5Y Avg)5.07%

P/E Excl Extra (TTM)14.06x

LT Debt / Equity (Quarterly)1.05x

EPS Basic Excl Extra (TTM)$3.57

P/B Ratio (Annual)1.49x

Inventory Turnover (TTM)2.99x

Pretax Margin (TTM)21.20%

Book Value / Share (Annual)$39.89

Price vs S&P 500 (13W)6.30%

Net Margin Growth (5Y)0.02%

Beta0.33x

P/FCF (Annual)9.82x

Revenue / Share (TTM)$23.21

ROE (TTM)9.22%

52-Week Low$42.62

vGradeB

gGradeC

mGradeC

vgmGradeC

PBH Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$0.88	$0.98	+12.00%(+$0.10)
Q1 2026	May 13, 2026	$1.39	$1.23	-11.51%(-$0.16)
Q4 2025	Feb 5, 2026	$1.16	$1.14	-1.36%(-$0.02)
Q3 2025	Nov 6, 2025	$0.97	$0.86	-11.34%(-$0.11)
Q2 2025	Aug 7, 2025	$0.99	$0.95	-4.23%(-$0.04)

PBH Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.20

4.00

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
PBHPrestige Consumer Healthcare Inc.	B	C	C	$52.47
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is a leading pure-play OTC healthcare provider with a portfolio of category-dominant brands including Clear Eyes, Dramamine, Monistat, and Summer's Eve. These brands maintain strong market positions backed by healthcare professional endorsements. The company generates approximately 85% of revenue from North America, with the remainder from Australia, New Zealand, and select Asian markets.